RAYMOND JAMES & ASSOCIATES - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,333,117
-32.4%
925,776
+16.9%
0.00%
-50.0%
Q2 2023$1,972,364
-1.5%
792,114
+6.0%
0.00%0.0%
Q1 2023$2,003,061
-26.1%
747,411
+49.8%
0.00%0.0%
Q4 2022$2,709,043
-54.8%
498,903
+4.0%
0.00%
-66.7%
Q3 2022$5,991,000
+176.8%
479,635
+9.5%
0.01%
+200.0%
Q2 2022$2,164,000
-28.4%
438,156
+10.1%
0.00%
-33.3%
Q1 2022$3,024,000
+28.0%
397,879
+72.0%
0.00%
+50.0%
Q4 2021$2,362,000
+30.6%
231,315
+71.7%
0.00%0.0%
Q3 2021$1,808,000
-37.9%
134,739
+1.6%
0.00%
-33.3%
Q2 2021$2,910,000
-1.4%
132,648
-0.7%
0.00%0.0%
Q1 2021$2,950,000
+13.1%
133,520
-7.9%
0.00%0.0%
Q4 2020$2,608,000
+37.3%
144,953
-11.9%
0.00%
+50.0%
Q3 2020$1,900,000
-48.7%
164,517
+7.7%
0.00%
-60.0%
Q2 2020$3,707,000
+2889.5%
152,788
+1253.9%
0.01%
Q1 2020$124,000
-46.8%
11,285
+28.0%
0.00%
Q4 2019$233,0008,8190.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders